The findings are published in the journal Nature Cell Biology.
Parietin, also known as physcion, shows no toxicity to human blood cells, the authors report. It could also be effective in treating lung and head and neck tumours they say.
Parietin appears to inhibit the metabolic enzyme 6PGD (6-phosphogluconate dehydrogenase), which is part of the response that causes rapid cellular growth. Researchers have already found 6PGD enzyme activity increased in several types of cancer cells.
“This is part of the Warburg effect, the distortion of cancer cells’ metabolism,” says team leader Jing Chen, professor of hematology and medical oncology at Emory University School of Medicine and Winship Cancer Institute.
“We found that 6PGD is an important metabolic branch point in several types of cancer cells.”
Bill Condie is a science journalist based in Adelaide, Australia.
Read science facts, not fiction...
There’s never been a more important time to explain the facts, cherish evidence-based knowledge and to showcase the latest scientific, technological and engineering breakthroughs. Cosmos is published by The Royal Institution of Australia, a charity dedicated to connecting people with the world of science. Financial contributions, however big or small, help us provide access to trusted science information at a time when the world needs it most. Please support us by making a donation or purchasing a subscription today.